Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Shares of Chegg, Inc. CHGG have lost 45.4% in the past three months compared with the Zacks Internet – Software industry’s 10.1% decline. Over the same timeframe, the broader Computer and Technology ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

The right online broker can help you execute your investment strategy and make trading cheap stocks seamless. Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap, but ...

Chegg, Inc. CHGG has redefined its business model with a new growth engine, Chegg Skilling, built by integrating Busuu and Chegg Skills. The cornerstone of this reinvention is its belief in the ...

Credit Human Share Certificates made our list of the best five-year CD accounts thanks to its competitive APY and relatively low minimum deposit requirement. We like that Credit Human Share ...

Paolo Banchero, Immanuel Quickley and Shai Gilgeous-Alexander deliver in the clutch, plus a lookahead to Thursday's slate. The Lakers' star duo delivers in New Orleans, Cooper Flagg puts away the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.